154 related articles for article (PubMed ID: 12831987)
41. 3-[123I]iodo-alpha-methyltyrosine and [methyl-11C]-L-methionine uptake in cerebral gliomas: a comparative study using SPECT and PET.
Langen KJ; Ziemons K; Kiwit JC; Herzog H; Kuwert T; Bock WJ; Stöcklin G; Feinendegen LE; Müller-Gärtner HW
J Nucl Med; 1997 Apr; 38(4):517-22. PubMed ID: 9098193
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and preliminary biological evaluation of S-11C-methyl-D-cysteine as a new amino acid PET tracer for cancer imaging.
Huang T; Tang G; Wang H; Nie D; Tang X; Liang X; Hu K; Yi C; Yao B; Tang C
Amino Acids; 2015 Apr; 47(4):719-27. PubMed ID: 25534431
[TBL] [Abstract][Full Text] [Related]
43. Analysis of 11C-methionine uptake in low-grade gliomas and correlation with proliferative activity.
Kato T; Shinoda J; Oka N; Miwa K; Nakayama N; Yano H; Maruyama T; Muragaki Y; Iwama T
AJNR Am J Neuroradiol; 2008 Nov; 29(10):1867-71. PubMed ID: 18687745
[TBL] [Abstract][Full Text] [Related]
44. Transport of cis- and trans-4-[(18)F]fluoro-L-proline in F98 glioma cells.
Langen KJ; Mühlensiepen H; Schmieder S; Hamacher K; Bröer S; Börner AR; Schneeweiss FH; Coenen HH
Nucl Med Biol; 2002 Aug; 29(6):685-92. PubMed ID: 12234594
[TBL] [Abstract][Full Text] [Related]
45. Imaging of amino acid transport in brain tumours: Positron emission tomography with O-(2-[
Langen KJ; Stoffels G; Filss C; Heinzel A; Stegmayr C; Lohmann P; Willuweit A; Neumaier B; Mottaghy FM; Galldiks N
Methods; 2017 Nov; 130():124-134. PubMed ID: 28552264
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of D-isomers of O-11C-methyl tyrosine and O-18F-fluoromethyl tyrosine as tumor-imaging agents in tumor-bearing mice: comparison with L- and D-11C-methionine.
Tsukada H; Sato K; Fukumoto D; Nishiyama S; Harada N; Kakiuchi T
J Nucl Med; 2006 Apr; 47(4):679-88. PubMed ID: 16595503
[TBL] [Abstract][Full Text] [Related]
47. Differentiation of tumour and inflammation: characterisation of [methyl-3H]methionine (MET) and O-(2-[18F]fluoroethyl)-L-tyrosine (FET) uptake in human tumour and inflammatory cells.
Stöber B; Tanase U; Herz M; Seidl C; Schwaiger M; Senekowitsch-Schmidtke R
Eur J Nucl Med Mol Imaging; 2006 Aug; 33(8):932-9. PubMed ID: 16604346
[TBL] [Abstract][Full Text] [Related]
48. Strategy based on kinetics of O-(2-[
Kameyama M; Umeda-Kameyama Y
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2267-2268. PubMed ID: 27514527
[No Abstract] [Full Text] [Related]
49. Comparison of O-(2-
Verger A; Filss CP; Lohmann P; Stoffels G; Sabel M; Wittsack HJ; Kops ER; Galldiks N; Fink GR; Shah NJ; Langen KJ
World Neurosurg; 2018 May; 113():e727-e737. PubMed ID: 29510293
[TBL] [Abstract][Full Text] [Related]
50. Synthesis, Radiolabeling, and Biological Evaluation of (R)- and (S)-2-Amino-5-[(18)F]fluoro-2-methylpentanoic Acid ((R)-, (S)-[(18)F]FAMPe) as Potential Positron Emission Tomography Tracers for Brain Tumors.
Bouhlel A; Zhou D; Li A; Yuan L; Rich KM; McConathy J
J Med Chem; 2015 May; 58(9):3817-29. PubMed ID: 25843369
[TBL] [Abstract][Full Text] [Related]
51. Evaluation of 4-borono-2-18F-fluoro-L-phenylalanine-fructose as a probe for boron neutron capture therapy in a glioma-bearing rat model.
Wang HE; Liao AH; Deng WP; Chang PF; Chen JC; Chen FD; Liu RS; Lee JS; Hwang JJ
J Nucl Med; 2004 Feb; 45(2):302-8. PubMed ID: 14960653
[TBL] [Abstract][Full Text] [Related]
52. Population Pharmacokinetic Approach Applied to Positron Emission Tomography: Computed Tomography for Tumor Tissue Identification in Patients with Glioma.
Gandia P; Jaudet C; Everaert H; Heemskerk J; Vanbinst AM; de Mey J; Duerinck J; Neyns B; de Ridder M; Chatelut E; Concordet D
Clin Pharmacokinet; 2017 Aug; 56(8):953-961. PubMed ID: 27995528
[TBL] [Abstract][Full Text] [Related]
53. Determination of an Optimal Pharmacokinetic Model of
Richard MA; Fouquet JP; Lebel R; Lepage M
J Nucl Med; 2017 Aug; 58(8):1278-1284. PubMed ID: 28765227
[No Abstract] [Full Text] [Related]
54.
Watabe T; Ikeda H; Nagamori S; Wiriyasermkul P; Tanaka Y; Naka S; Kanai Y; Hagiwara K; Aoki M; Shimosegawa E; Kanai Y; Hatazawa J
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):321-331. PubMed ID: 27550420
[TBL] [Abstract][Full Text] [Related]
55. Investigation of transport mechanism and uptake kinetics of O-(2-[18F]fluoroethyl)-L-tyrosine in vitro and in vivo.
Heiss P; Mayer S; Herz M; Wester HJ; Schwaiger M; Senekowitsch-Schmidtke R
J Nucl Med; 1999 Aug; 40(8):1367-73. PubMed ID: 10450690
[TBL] [Abstract][Full Text] [Related]
56. [Synthesis and radiopharmacology of S-(2-18F-fluoroethyl)-L-methionine for tumor imaging].
Tang GH; Wang MF; Tang XL; Luo L; Gan MQ
Yao Xue Xue Bao; 2003 Dec; 38(12):915-8. PubMed ID: 15040084
[TBL] [Abstract][Full Text] [Related]
57. Correlation between dynamic susceptibility contrast perfusion MRI and methionine metabolism in brain gliomas: preliminary results.
Sadeghi N; Salmon I; Tang BN; Denolin V; Levivier M; Wikler D; Rorive S; Balériaux D; Metens T; Goldman S
J Magn Reson Imaging; 2006 Nov; 24(5):989-94. PubMed ID: 17031832
[TBL] [Abstract][Full Text] [Related]
58. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas.
Barth RF; Yang W; Adams DM; Rotaru JH; Shukla S; Sekido M; Tjarks W; Fenstermaker RA; Ciesielski M; Nawrocky MM; Coderre JA
Cancer Res; 2002 Jun; 62(11):3159-66. PubMed ID: 12036929
[TBL] [Abstract][Full Text] [Related]
59. Syntheses of F-18 labeled fluoroalkyltyrosine derivatives and their biological evaluation in rat bearing 9L tumor.
Moon BS; Lee TS; Lee KC; An GI; Cheon GJ; Lim SM; Choi CW; Chi DY; Chun KS
Bioorg Med Chem Lett; 2007 Jan; 17(1):200-4. PubMed ID: 17035015
[TBL] [Abstract][Full Text] [Related]
60. Detection of remote neuronal reactions in the Thalamus and Hippocampus induced by rat glioma using the PET tracer cis-4-[¹⁸F]fluoro-D-proline.
Geisler S; Willuweit A; Schroeter M; Zilles K; Hamacher K; Galldiks N; Shah NJ; Coenen HH; Langen KJ
J Cereb Blood Flow Metab; 2013 May; 33(5):724-31. PubMed ID: 23385199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
